<p>Sinolink Securities 的分析师昨日对 Keymed Biosciences, Inc. 维持了买入评级，并设定了目标价为 83.29 港元。</p>
<h3>在这个假期季节，TipRanks 限时七折优惠</h3>
<ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
<p>Keymed Biosciences, Inc. 的分析师共识为强烈买入，目标价共识为 88.61 港元。</p>

康诺亚-B

<p>Sinolink Securities 的分析师昨日对 Keymed Biosciences, Inc. 维持了买入评级，并设定了目标价为 83.29 港元。Claim 70% Off TipRanks This Holiday SeasonUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential。Keymed Biosciences, Inc. 的分析师共识为强烈买入，目标价共识为 88.61 港元</p>

<p>Sinolink Securities analyst maintained a Buy rating on Keymed Biosciences, Inc. yesterday and set a price target of HK$83.29.</p>
<div class="lb-trans"><p>Sinolink Securities 的分析师昨日对 Keymed Biosciences, Inc. 维持了买入评级，并设定了目标价为 83.29 港元。</p>
</div><h3>Claim 70% Off TipRanks This Holiday Season</h3>
<div class="lb-trans"><h3>在这个假期季节，TipRanks 限时七折优惠</h3>
</div><ul>
<li>Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions</li>
<li>Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential</li>
</ul>
<div class="lb-trans"><ul>
<li>解锁对冲基金级别的数据和强大的投资工具，以做出更聪明、更精准的决策</li>
<li>通过最新的新闻和分析保持市场领先，最大化您的投资组合潜力</li>
</ul>
</div><p>Keymed Biosciences, Inc. has an analyst consensus of Strong Buy, with a price target consensus of HK$88.61.</p>
<div class="lb-trans"><p>Keymed Biosciences, Inc. 的分析师共识为强烈买入，目标价共识为 88.61 港元。</p>
</div>

康诺亚-B（2162）获得国金证券的买入评级